25.03.2014
NEXUS AG DE0005220909
DGAP-Adhoc: NEXUS AG: Substantial sales and revenue growth in 2013
NEXUS AG / Key word(s): Final Results
25.03.2014 08:32
Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------
Villingen-Schwenningen, 25 March 2014: NEXUS AG, Villingen-Schwenningen,
listed in Prime Standard increased its consolidated sales of KEUR 62,340 in
the previous year to KEUR 73,263 (+17.5%) in 2013. The Group annual surplus
increased by 26.1% to KEUR 7,220 (previous year: KEUR 5,728).
NEXUS AG was again able to achieve two-figure growth both in sales and
revenue in 2013 and consequently continue its development of the previous
years.
Sales in the core business, Health Care Software, increased by 14.1% to
KEUR 64,940 (previous year: KEUR 56,921) over the whole year. The
Healthcare Service Division had approx. 53.6% higher sales with KEUR 8,323
than in the previous year (KEUR 5,419). The foreign share of Group sales
was 42.8% compared to 44.7% in the same period of the previous year.
The Group annual surplus was KEUR 7,220 following KEUR 5,728 in 2012
(+26.1%). The Group result before tax on income improved from KEUR 5,789 in
2012 to KEUR 7,078 (+22.3%). The EBITDA reached KEUR 13,998 following KEUR
11,820 in the previous year (+18.4%). The result per share increased by
19.1% to 50 cents (2012: 42 cents).
On 31 December 2013, the balance sheet showed stockholders equity
amounting to approx. KEUR 72,369 (previous year: KEUR 68,113) as well as
cash and securities in the amount of KEUR 23,804 (previous year: KEUR
23,051). There are no essential bank liabilities. The equity capital rate
was 71.0%.
The Supervisory Board and the Executive Board will proposed at the
annual general meeting to pay a dividend of 12 cents per share.
---------------------------------------------------------------------------
Information and Explaination of the Issuer to this News:
NEXUS AG - the e-health specialist - develops and sells IT solutions for
healthcare systems. These solutions make it possible for hospitals, senior
citizen homes, rehabilitation and social institutions to convert to digital
patient information. NEXUS also supports integrated healthcare, which
enables data exchange between primary care physicians, hospitals and
rehabilitation clinics. More than 644 staff members in the NEXUS Group
develop Software solutions for the healthcare sector, with which
approximately 180,320 users in 25 countries work worldwide on a daily
basis.
25.03.2014 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: NEXUS AG
Auf der Steig 6
78052 Villingen-Schwenningen
Germany
Phone: +49 (0)7721 8482-0
Fax: +49 (0)7721 8482-311
E-mail: [email protected]
Internet: www.nexus-ag.de
ISIN: DE0005220909
WKN: 522090
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, München, Stuttgart
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
|
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu
NEXUS AG ISIN: DE0005220909 können Sie bei EQS abrufen
Software , 522090 , NXU , XETR:NXU